JOHNSON & JOHNSON |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 146.4 USD | -1.29% |
|
0.00% | -6.76% |
| 06-28 | Johnson & Johnson Reports 'Positive' Results in Late-Stage Myasthenia Gravis Trial | MT |
| 06-28 | J&J Unit's Rybrevant Combo Gets EU Approval | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 815B | ||||||
| 641B | ||||||
| 314B | ||||||
| 303B | ||||||
| 242B |
